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Localized 
1H-MR Spectroscopy in
Moyamoya Disease before and after
Revascularization Surgery
Objective: To evaluate, using localized proton magnetic resonance spec-
troscopy (
1H-MRS), the cerebral metabolic change apparent after revasculariza-
tion surgery in patients with moyamoya disease.
Materials and Methods: Sixteen children with moyamoya disease and eight
age-matched normal controls underwent MR imaging, MR angiography, conven-
tional angiography, and 
99mTc- ECD SPECT. Frontal white matter and the basal
ganglia of both hemispheres were subjected to localized 
1H-MRS, and after
revascularization surgery, four patients underwent follow-up 
1H-MRS.
Results: Decreased NAA/Cr ratios (1.35 0.14 in patients vs. 1.55 0.24 in
controls) and Cho/Cr ratios (0.96 0.13 in patients vs. 1.10 0.11 in controls)
were observed in frontal white matter. After revascularization surgery, NAA/Cr
and Cho/Cr ratios in this region increased. In the basal ganglia, there is no abnor-
mal metabolic ratios.
Conclusion: Localized 1H-MRS revealed abnormal metabolic change in both
hemispheres of children with moyamoya disease. Because of its non-invasive
nature, 
1H-MRS is potentially useful for the preoperative evaluation of metabolic
abnormalities and their postoperative monitoring.
oyamoya disease involves slowly progressive stenosis in bilateral proxi-
mal intracranial vessels, leading to reduced cerebral perfusion (1, 2).
Symptoms such as headaches and unilateral or bilateral transient ischemic
attacks develop in young children, especially during hyperventilation (2, 3). Although
the exact cause of the disease is still unknown and the specifics of its natural course are
a matter of controversy, its outcomes range from reversible ischemia to cerebral in-
farction associated with permanent neurological deficits and intellectual impairment
(4, 5). Early diagnosis followed by accurate treatment is, therefore, critically impor-
tant, especially for young children.
Revascularization surgery in pediatric patients with moyamoya disease has been
shown to be an effective treatment method (6, 7). At present, cerebral or MR angiog-
raphy and MR imaging are modalities by means of which the disease can be diagnosed
with confidence; in addition, single photon emission tomography (SPECT) provides
confirmation of the diagnosis and is used to evaluate the cerebral perfusion reserve. 
Localized proton MR spectroscopy (
1H-MRS) has recently been used to detect the
metabolic changes occurring in the brain in numerous diseases (8). Its noninvasive na-
ture has increasingly attracted the attention of pediatricians, who see it as a promising
application (9, 10). Although localized 
1H-MRS has been used in patients with internal
carotid artery flow lesions (11), it has never been employed in those with moyamoya
disease. In regions without infarction but with severely reduced internal carotid flow,
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M1H-MRS has demonstrated decreased NAA/Choline ratios
and a high incidence of cerebral lactate (11), and it can be
inferred that in the brains of patients with moyamoya dis-
ease, NAA and/or Choline levels are lower than normal. In
this study we used localized 
1H-MRS to measure changes in
the cerebral metabolite levels found in moyamoya disease
before and after revascularization surgery. Our hypothesis
is that localized 
1H MRS can be used to preoperatively
evaluate cerebral metabolic abnormalities, and to monitor
these postoperatively.
MATERIALS AND METHODS
Subjects
Our study group consisted of 16 consecutive children
aged 3 13 (mean, 7.6) years in whom moyamoya disease
was diagnosed between March 1998 and December 1999,
and eight age-matched normal controls aged 4-11 (mean,
8) years. Diagnosis was based on the findings of conven-
tional angiography (n=12), MR imaging (n=16), MR an-
giography (n=7), SPECT (n=16), and clinical symptoms.
Nine children showed unilateral symptoms of transient is-
chemic attack and six had bilateral symptoms; at the time
of initial diagnosis, these included TIA (n=15), headache
(n=3), seizure (n=2) and/or aphasia (n=2). All patients un-
derwent initial 
1H-MRS, and four underwent follow-up 
1H-
MRS 6 19 months after surgery (encephalo-duro-arterio-
myo-synangiosis; EDAMS). In three patients (numbers 1,
4, 11), revascularization surgery was performed in both
hemispheres, and in one (number 7), in the left hemisphere
only. These four patients underwent follow-up SPECT 6
22 months after surgery.
All patients and normal controls gave their informed
consent to 
1H-MRS. The study protocol conformed to the
ethical guidelines of the 1975 Declaration of Helsinki, as
reflected in its approval by our institution’s Human
Research Committee.
MRI, MR Angiography, Cerebral Angiography, and
99mTc-ECD SPECT
For MR imaging and angiography, a 1.5T scanner
(Magnetom Vision, Siemens, Erlangen, Germany) was
used, and in all patients, T1-weighted (TR/TE:600/11 20)
and T2-weighted (TR/TE:3500/102) spin-echo images, as
well as Gd-DTPA (Magnevist, Schering, Germany)-en-
hanced T1-weighted images, were acquired. In seven pa-
tients, MR angiography with a three-dimensional time-of-
flight (3D-TOF) sequence was performed.
Twelve patients underwent transfemoral cerebral angiog-
raphy using an Integris BN 3000 biplane (Philips Medical
System, Eindhoven, Netherlands), after injection of the bi-
lateral internal and external carotid and unilateral verte-
bral artery. Grading of the involved vessels was based on
Suzuki’s classification (3).
Using a Triad XLT20 (Trionix, Twinsburg, U.S.A.)
equipped with a LEUR collimator interfaced to a Sun
Sparc workstation, serial dynamic SPECT scans (1min 50
frames) were obtained in 16 patients. Two doses of 
99mTc-
ECD (ethyl cysteinate dimmer) were administered, one at
the onset of scanning (20mCi) and one at 30 mins (20mCi).
Diamox (1g) was injected intravenously at 10 mins. Two
nuclear physicians visually assessed the perfusion status,
comparing it with that of cerebellar perfusion.
Localized 
1H-MRS
Using a 1.5T system (Signa; GE Medical Systems,
Milwaukee, U.S.A.) equipped with shielded gradients, lo-
calized in-vivo
1H-MRS was performed 1 2 weeks after
T2-weighted MRI was used to localize and evaluate any
changes in brain parenchymal signal intensity, compared to
previous MRI findings. Image-guided STEAM spectra were
obtained from frontal white matter at the border zone be-
tween anterior and middle cerebral artery territory and the
basal ganglia in both hemispheres, avoiding areas of old in-
farcts or abnormal signal intensities (Figs. 1A, 2A). The
spectroscopic acquisition parameters were as follows: TR=
3.0 sec/ TE=30 msec, and NS=36 AVG with PROton Brain
Exam (PROBE) (GE Medical Systems). Voxel volumes
were 7 9 ml, and a 3-pulse CHESS (CHEmical Shift
Selective) sequence was used for suppression of the H2O
signal.
All raw data were transferred to a Sun Sparc-10 work-
station (SUN Computer Inc., Sunnyvale, U.S.A.), and
processed using Spectral Analysis/General Electric
(SA/GE) software (GE Medical Systems) incorporating low
frequency filtering of residual water signal, apodization by
0.5 Hz of exponential line broadening, zerofilling of 8k,
Fourier transformation, and lorenzian to gaussian transfor-
mation according to the scheme described by Kreis et al.
(12). Metabolic peaks were fitted by the lorenzian line
shape at known frequencies of N-acetylaspartate (NAA) at
2.02 ppm, creatine (Cr) at 3.03 ppm, choline and choline-
containing compounds (Cho) at 3.22 ppm, and myo-
Inositol (mI) at 3.56 ppm. The values of the [NAA/Cr],
[Cho/Cr], and [mI/Cr] ratios were calculated.
Assessment
The spectroscopic data were expressed as mean stan-
dard error. Mean (right and left) metabolite ratios between
patients and normal controls, and between symptom-relat-
ed and other hemispheres were compared using the Mann-
Whitney U test. In four patients, changes in metabolite ra-
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test. For statistical analyses, SPSS Windows (SPSS for
Windows, SPSS Inc., Chicago, U.S.A.) was used.
RESULTS
Tables 1 and 2 summarize the clinical data and findings
at MR imaging, angiography, SPECT, and 
1H-MRS (Figs. 1,
2).
Localized 
1H-MRS revealed decreased NAA/Cr and
Cho/Cr ratios(Fig. 1F) in 16 patients, in whom mean
NAA/Cr, Cho/Cr, and mI/Cr ratios were 1.35 0.14, 0.96
0.13, and 0.68 0.12, respectively, in frontal white mat-
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Table 1. Clinical History and Findings of MRI, Angiography and SPECT in Patients with Moyamoya Disease
Patient Age/Sex Symptoms and MR imaging Angiography Reduced perfusion at SPECT
No. Duration (yrs) (MRA) (Suzuki stage) Basal Diamox
1 3/M Rt. arm and leg weakness, No infarct Rt. (II) Rt. ACA,  Both ACA, 
rt. facial weakness(1) ( ) Lt. (I) MCA MCA
2 4/F Weakness of No infarct Rt. (II)  Rt. ACA, Both ACA,
both hands (1) Lt. (III)  MCA  MCA
3 5/F Lt. arm and leg Old infarct at Rt. (II) Rt. ACA No change
weakness (1.5) rt. MCA Lt. (III)
4 6/M Weakness of  No infarct  Rt. (II) Rt. ACA,  Both ACA, 
both legs (3) ( ) Lt. (III) MCA MCA
5 6/F Rt. arm and leg No infarct Rt. (II) Normal Both ACA,
weakness, headache (2) Lt. (II) MCA
6 6/F Weakness of  Old infarct at  Rt. (III) Normal Both ACA, 
the rt. hand(1) watershed of  Lt. (III) MCA
lt. MCA, PCA
7 6/M Rt. arm weakness, Cortical atrophy Both MCA Both ACA,
seizure (3) at lt. MCA ( ) MCA
8 7/M Weakness of Old infarct at  Both ACA,  No change
both hands (3) both ACA, MCA ( ) MCA, PCA
9 8/F Mental  No infarct Rt. (II) Normal Both ACA,
retardation (5) Lt. (III) MCA
10 8/M Lt. arm and leg No infarct Rt. (II) Rt. MCA No change
weakness, aphagia (4) Lt. (II)
11 9/F Weakness of No infarct Rt. (II) Normal Both ACA,
both hands (3) ( ) Lt. (III) MCA
12 9/F Weakness of Old infarct at Lt. ACA Both ACA
both hands, headache (3) lt. ACA ( )
13 9/M Rt. arm and leg Old infarct at watershed of Rt. MCA No change
weakness, aphagia (1.5) Lt. MCA, PCA ( )
14 11/M Lt. arm and leg No infarct Rt. (III) Rt. ACA,  No change
weakness, seizure (3) Lt. (III) MCA, PCA
15 11/M Weakness of  Acute infarct at  Rt. (IV)  Rt. MCA Both ACA
both legs and Rt.frontal cortex,  Lt. (IV)
hands, headache (3) Lt. FWM
16 13/M Rt. arm and leg No infarct Rt. (II) Normal Normal
weakness (5) Lt. (III)
Note. FWM=frontal white matter, ACA=anterior cerebral arterial territory, MCA=middle cerebral arterial territory, PCA=posterior cerebral arterial territory,
F=female, M=male, Rt= right, Lt.=Left
Table 2.
1H-MRS Results in Patients with Moyamoya Disease
Compared with Normal Controls
Normal controls (n=8) Moyamoya disease (n=16)
FWM BG FWM BG
NAA/Cr 1.55 0.24 1.21 0.14 1.35 0.14 1.13 0.14
Cho/Cr 1.10 0.11 0.77 0.10 0.96 0.13 0.73 0.07
mI/Cr 0.64 0.08 0.45 0.07 0.68 0.12 0.44 0.07
Note. The values are averages, measured in both hemispheres.
NAA/Cr and Cho/Cr ratios were statistically significantly different (p < 0.05).
FWM=frontal white matter, BG=basal gangliaLim et al.
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Fig. 1. MRI, basal and diamox stress SPECT, cerebral angiography and 
1H-MR spectra obtained in patient No. 5.
A. T2-weighted axial image shows a voxel location for 1H-MRS and no abnormal signal intensity in the brain.
B. Basal SPECT (axial view) discloses normal uptake in both hemispheres.
C. Diamox stress SPECT (axial view) reveals decreased uptake in both hemispheres.
D. Arterial-phase angiogram of the left common carotid artery (frontal view) shows marked stenosis of the distal internal carotid and ante-
rior and middle cerebral arteries, with tortuous and dilated medial and lateral lenticulostriate vessels (Suzuki stage II).
E. Arterial-phase angiogram of the right common carotid artery (frontal view) demonstrates findings similar to those of the left side
(Suzuki stage II).
F. Representative 
1H-MR spectra of frontal white matter (both sides) show lower NAA/Cr [Lt(b): 1.21, Rt(c): 1.34], Cho/Cr [Lt(b): 0.71, Rt
(c): 0.77] ratios than in an age-matched control (a).
ppm
FWM in normal control (a)
ppm
Lt FWM in moyamoya Pt (b)
ppm
Rt FWM in moyamoya Pt. (c)ter, compared with 1.55 0.24, 1.10 0.11, and 0.64
0.08 in normal controls (p<0.05). In patients, mean
NAA/Cr, Cho/Cr, and mI/Cr ratios were 1.13 0.14, 0.73
0.07, and 0.44 0.07, respectively, in both basal ganglia,
while the corresponding figures for normal controls were
1.21 0.14, 0.77 0.10, and 0.45 0.07. Reduced
NAA/Cr and Cho/Cr ratios were detected in 13 patients,
while in three, the Cho/Cr ratio had increased. In two of
these three, the NAA/Cr ratio had decreased, and in one it
was normal.
In the symptomatic hemisphere, NAA/Cr, Cho/Cr and
mI/Cr ratios were 1.35 0.28, 0.89 0.26, and 0.67
0.18, respectively, while on the asymptomatic side, the re-
spective readings were 1.33 0.28, 0.93 0.24, and 0.68
0.22. The differences between the two hemispheres were
not statistically significant.
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Fig. 2. MRI, cerebral angiography and 
1H-MR spectra obtained in patient No. 1.
A. T2-weighted axial image shows no abnormal signal intensity in the brain.
B. Arterial-phase angiogram of the left common carotid artery (frontal view) reveals nar-
rowing of the carotid fork (Suzuki stage I).
C. Angiogram of the right common carotid artery (frontal view) shows the beginning of
basal moyamoya vessels, and narrowing of the supraclinoid internal carotid and anterior
and middle cerebral arteries (Suzuki stage II).
D.
1H-MR spectra of frontal white matter (both sides) obtained after revascularization
surgery disclose an increased NAA/Cr ratio [Lt(b): 1.56, Rt(d): 1.41] and a slightly in-
creased upper normal range of Cho/Cr [Lt(b): 1.23, Rt(d): 1.20] as compared with pre-
operative NAA/Cr [Lt(a): 1.24, Rt(c): 1.14] and Cho/Cr [Lt(a): 0.93, Rt(c): 1.02] levels.
Preop Lt FWM (a)
Preop Rt FWM (c)
Postop Lt FWM (b)
Postop Rt FWM (d)Four patients underwent follow-up 
1H-MRS 6 to 19
months after revascularization surgery: their NAA/Cr ra-
tios had increased (p < 0.05), slightly overshooting Cho/Cr
ratios in the hemispheres (Fig. 2D) with improved symp-
toms of transient ischemic attack (Table 3). One of the four
patients (number 7, Table 3) still exhibited TIA symptoms
on the side not operated on, and the NAA/Cr ratio in
frontal white matter remained low. Cho/Cr ratios were
slightly overshot in all four patients, but were still within
the upper normal limit. Basal and diamox stress SPECT
showed increased perfusion in both hemispheres of all four
patients, as compared with the preoperative results.
DISCUSSION
N-acetylaspartate is known to be a neuronal marker, and
a decrease in its level indicates a loss of neurons or neu-
ronal activity owing to myelin breakdown, as occurs in
brain infarct, tumor, and radiation injury (13). Choline ap-
pears to contain contributions from phosphorylcholine and
glycerophosphorylcholine, which are, respectively, a pre-
cursor to cell membrane and a product of its breakdown.
An increased choline signal is therefore thought to be an
indicator of active demyelination (14).
Duijin et al. (15) and Lanfermann et al. (16) observed de-
creased choline levels in chronic, but not acute or subacute,
infarctions. In their study, they also observed that choline
and creatine decreased to a lesser extent than N-acetylas-
partate in the peripheral region of the infarcted lesion. This
may explain the loss of neuronal function while glial cellu-
lar structure in the peripheral region is still intact. In our
patients, the abnormal NAA/Cr and Cho/Cr values found
in frontal white matter may also indicate a loss of neuronal
function, a hypothesis supported by the normal MRI find-
ings and absence of a lactate peak. A lactate signal is an
end product of anaerobic glucose metabolism, suggesting
that this ischemic process may be more likely in the chron-
ic than in the acute state.
Children with moyamoya disease suffer from headache
and unilateral or bilateral transient ischemic attack (2, 3),
even if they do not have persistent neurological deficits.
Decreased cerebral blood flow and cerebral perfusion re-
serve have been demonstrated in patients with the disease,
and these lead to ischemic neurologic symptoms (17 25).
CT and MRI are useful for the detection of infarction, but
their ability to detect perfusion disturbances is limited.
SPECT demonstrates the degree and region of hemody-
namic compromise and is commonly used to determine
suitable surgical candidates. It cannot, however, disclose
metabolic change as a consequence of chronic cerebral is-
chemia. As shown in this study, 
1H-MRS, which is noninva-
sive, can provide information on deranged metabolites un-
der conditions of chronic cerebral hypoperfusion.
In this study, the findings of 
1H-MRS appear to suggest a
slightly greater decrease in Cho/Cr ratios in symptom-re-
lated hemispheres, but the differences were not statistically
significant. Further investigation involving a large series
with asymmetric involvement of both hemispheres would
help clarity this issue.
In three of 16 patients, Cho/Cr ratios had increased and
NAA/Cr ratios had decreased or were normal. Rutgers et
al. (26) described the cerebral metabolic changes observed
at 
1H-MRS in patients with symptomatic occlusion of the
internal carotid artery. During the period of acute infarc-
tion, the NAA/Cr ratio was significantly lower than in con-
trol subjects in the hemisphere ipsilateral to ICA occlusion,
and the Cho/Cr ratio was significantly higher. Subsequent-
ly, the Cho/Cr ratio decreased significantly and returned to
the control value. These findings suggest that increased
Cho/Cr ratios may indicate an acute process.
Various revascularization procedures such as EDAMS
have served to increase the blood supply to ischemic areas
of the brain, and in this study, symptoms of transient is-
chemic attack disappeared or improved in three patients
after revascularization surgery, and NAA/Cr ratios in-
creased. Increased N-acetylaspartate levels have been rec-
ognized only in Canavan’s disease and in infants during
normal development (27, 28), and could account for
changes in N-acetylaspartate metabolism and/or neuronal
activity (29). In this study, another finding after revascular-
ization surgery was that Cho/Cr ratios had slightly over-
shot. It has been reported that the choline levels increased
to above the normal limit after liver transplantation and
that this was due to cyclosporine related encephalopathy
or neurotoxicity (8). The patients in our study did not,
however, undergo immunosuppressive treatment, and it
Lim et al.
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Table 3. Metabolic Changes Occurring in Frontal White
Matter after Revascularization Surgery in Moyamoya
Disease
Patient No.
NAA/Cr Cho/Cr
Right FWM Left FWM Right FWM Left FWM
Pre/Post Pre/Post Pre/Post Pre/Post
01 1.44/1.77 1.37/2.03 1.22/1.55 0.99/1.77
04 1.14/1.41 1.24/1.56 1.02/1.20 0.93/1.23
07 1.36/1.25 1.45/1.67 0.97/1.17 0.75/1.26
11 1.50/1.53 1.61/1.60 1.46/1.05 1.16/1.39
Note. Three patients (Nos. 1, 4, 11) underwent revascularization
surgery in both hemispheres, and one patient (No. 7) in the left
hemisphere only. The increase in NAA/Cr after surgery was statistically
significant (p < 0.05). Pre=preoperative, Post=postoperative, FWM=frontal
white mattercan therefore be inferred that increased perfusion after
revascularization surgery may transiently influence the
level of choline. Further study and long-term follow-up of
choline levels are therefore needed.
It has been shown that in moyamoya disease, vascular
reserve in the cerebral cortex of anterior and middle cere-
bral artery territory is significantly lower than in posterior
cerebral artery territory and the central region around the
basal ganglia and thalami (30 32). The results of our study
indicated that in both basal ganglia, metabolite levels were
normal, though it may be speculated that metabolic change
might occur there at a later stage of the disease, when basal
collaterals disappear.
In conclusion, localized 
1H-MRS in patients with
moyamoya disease demonstrated bilaterally decreased N-
acetylaspartate and choline ratios. 
1H-MRS effectively
measures the metabolic changes occurring in the brain in
moyamoya disease, and its non-invasive nature lends itself
to the preoperative evaluation of metabolic abnormality
and its postoperative monitoring.
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